Abstract: N-Acetyl-L-aspartate (NAA) and its derivative N-acetylaspartylglutamate (NAAG) are major osmolytes present in the vertebrate brain. Although they are synthesized primarily in neurons, their function in these cells is unclear. In the brain, these substances undergo intercompartmental cycles in which they are released by neurons in a regulated fashion and are then rapidly hydrolyzed by catabolic enzymes associated with glial cells. Recently, the catabolic enzyme for NAA hydrolysis has been found to be expressed only in oligodendrocytes, and the catabolic enzyme for NAAG expressed only in astrocytes. These results indicate an unusual tricellular metabolic sequence for the synthesis and hydrolysis of NAAG wherein it is synthesized in neurons from NAA and L-glutamate, hydrolyzed to NAA and L-glutamate by astrocytes, and further hydrolyzed to L-aspartate and acetate by oligodendrocytes. Since the discovery that the NAA and NAAG anabolic products of neurons are specifically targeted to oligodendrocytes and astrocytes, respectively, this unique metabolic compartmentalization also suggests that these substances may play an important role in cell-specific glial signaling. In this review, it is hypothesized that a key function of NAA and NAAG in the vertebrate brain is in cell signaling and that these substances are important in the regulation of interactions of brain cells and in the establishment and maintenance of the nervous system. Key Words: Astrocytes-Canavan disease-Cell signaling-Microglia-N-Acetylaspartate-N-Acetylaspartylglutamate-Neurons-Oligodendrocytes. J. Neurochem. 75, 453-459 (2000).
After the differentiation of neural crest pluripotent stem cells into cells that are destined to develop into neurons, oligodendrocytes, astrocytes, and microglia in the incredibly complex cytoarchitecture of the vertebrate CNS, and into Schwann cells in the PNS, a developmental period requiring a great degree of plasticity is initiated. During this period, each of these cell types must respond to the others, within a three-dimensional system over a period of time and operating over relatively long distances, to carry out their programmed functions. Neurons must find and create synaptic connections with other neurons (Hohmann and Berger-Sweeney, 1998) . Oligodendrocytes and Schwann cells must locate appropriate neuron axons and interact to form all of the components associated with the creation of an insulating myelin sheath (Vartanian et al., 1997; Popko, 2000) . Astrocytes must locate neuron synapses, axonal internodes, and capillary endothelial cells in the CNS for the placement of astrocytic end-feet, and locate neuron cell bodies and oligodendrocytes for the formation of an extensive network of gap junctions (Froes and Campos De Carvalho, 1998) , all of which are involved in astrocytic nutritive, communicative, and metabolic support roles. Finally, microglia must be made to sense the general condition and structural relationships of the developing CNS, to be able to migrate within the system to carry out their specific immunocompetent support role (Inoue et al., 1999) .
There are three phases that can be described in the association of differentiated brain cells. These phases include long-range cell signaling and recognition, cellto-cell docking, and finally the establishment of longterm intercellular functional relationships. In this review, a basic intercellular signaling mechanism operating in the CNS and PNS in which all of these cells participate, and which appears to use a small number of cell-specific enzyme-restricted chemical codes for long-range bidirectional communication between these cells, is described.
N-ACETYL-L-ASPARTATE (NAA) IN THE CNS AND ITS RELATIONSHIP TO CANAVAN DISEASE (CD)
Discovery of NAA The presence of large amounts of NAA in the vertebrate brain was first discovered by Tallan et al. (1956) , and although its synthesis by neurons and its intercompartmental catabolic metabolism are now well known (Birken and Oldendorf, 1989; Baslow, 1997) , the nature of the second metabolic compartment and an understanding of the function of NAA in the CNS remained elusive.
Discovery of the inborn error in NAA metabolism in CD
A possible clue to this function came in 1988, when it was observed that a lack of the NAA catabolic enzyme in the brain was a major characteristic of individuals suffering from CD, a rare and profound early-onset spongiform leukodystrophy (Matalon et al., 1988) . The clinical symptoms associated with CD have been reviewed recently (Baslow and Resnik, 1997; Matalon 1997; Traeger and Rapin, 1998; Leone et al., 1999) . Although the disease may sometimes appear after several years, an early-onset form of CD is usually observed within the first few months of life and may be characterized by initial apathy and, as the disease progresses, by optic atrophy, megaloencephaly, ataxia, myoclonus, and some form of epilepsy. At later stages, there may be considerable psychomotor and mental retardation and a failure to meet developmental milestones, such as holding the head up, grasping at objects, speech, and walking. Before death in several years, there may be spasticity and paralysis. In early-onset CD, the most important clinical clue to disease diagnosis, and one that distinguishes it from all other leukodystrophies, is the finding of increased levels of NAA in the brain, as well as the presence of NAA in blood and urine of these patients. The metabolism of N-acetylaspartylglutamate (NAAG), an NAA-glutamate (Glu) adduct that is synthesized primarily in neurons, is also disturbed in CD, and NAAG aciduria has been identified in these individuals (Burlina et al., 1994) .
CD is a globally distributed genetic autosomally inherited recessive disease involving mutations of a gene on chromosome 17 that is responsible for production of the catabolic enzyme for NAA hydrolysis. There are 29 types of specific genetic variations presently known (Matalon, 1997; Elpeleg and Shaag, 1999) . These mutations, which result in the production of an inactive enzyme, are associated with progressive oligodendrocyte myelinsheath deconstruction and eventual loss of oligodendrocytes and of the axon's myelin sheath, although the axons themselves remain intact. From this observation, it became apparent that the metabolism of NAA is very important to the interaction of neurons and oligodendrocytes, as well as to the maintenance of the integrity of myelinating oligodendrocytes. However, the precise function of NAA and its metabolic intercompartmental cycle, and how that function interacted with oligodendrocytes and was related to the CD syndrome, were still unclear. Based on the lack of hydrolytic enzyme activity in CD, it was suggested that the demyelination process may be initiated as a result of the continuous efflux of NAA from neurons, leading to increased NAA osmotic pressure exerted at the axon-oligodendrocyte paranodal junction, and resulting in the rupture of the axon-oligodendrocyte junctional seals (Baslow, 1999a) .
Although CD is the only neurodegenerative disease for which a definite link to an inborn error in NAA metabolism has been established, changes in the levels of brain NAA and NAAG have been observed in many unrelated disease processes. These changes, which are suggested to be indicative of changes in either neuron survival or neuron function, have been reported in a wide variety of neuropathological and neuropsychiatric disorders (Tsai and Coyle, 1995; Coyle, 1997) .
THE CELLULAR LOCALIZATION OF THE NAA AND NAAG CATABOLIC ENZYMES

Previous studies
Previous immunolocalization studies indicated that the NAA catabolic enzyme was myelin-associated, suggesting that it was found in oligodendrocytes (Kaul et al., 1991) , and by using in situ hybridization histochemistry, the NAAG catabolic enzyme was identified with astrocytes (Luthi-Carter et al., 1998) . However, neither of these in situ techniques, which deal with a variety of cells in complex and intimate association with one another, could adequately resolve the question of whether these enzymes were limited to the identified cell types. In an earlier study using cell culture techniques (Cassidy and Neale, 1993) , it was demonstrated that pure mouse brain astrocytes in culture contained large amounts of the NAAG catabolic enzyme. However, in that study, no information was obtained with regard to the presence or absence of this enzyme in oligodendrocytes or other pure cell lines. An association of aspartoacylase activity with cultured rat brain oligodendrocytes has been reported in abstract form (Shinar et al., 1995) . However, details of the study have yet to be published.
Discovery of the second compartments in NAA and NAAG metabolism
Recently, the question of the specific locations of the NAA and NAAG catabolic enzymes in glial cells has been clarified, and the second compartments in the NAA and NAAG cycles discovered. This has been accomplished by using isolated cultured rat brain cells, of a high degree of purity, and from these studies additional metabolic clues to the functions of NAA and NAAG have been revealed. These clues are based on the results of two independent investigations. First, it has been found that the expression of the gene for the enzyme that hydrolyzes NAA to L-aspartate (Asp) and acetate is limited to mature oligodendrocytes, with little or no enzyme activity in astrocytes, and that this occurs at a time prior to oligodendrocyte participation in the formation of a myelin sheath (Baslow et al., 1999) . Second, it has been found that the expression of the gene for the catabolic enzyme that cleaves NAA from NAAG is limited to astrocytes, with little or no enzyme activity in oligodendrocytes or microglia, and that this is evident at a time prior to astrocyte formation of gap junctions or other cell-to-cell associations (Berger et al., 1999) .
Clearly, these results indicate for the first time that release of NAA by neurons is specifically targeted to oligodendrocytes, and the release of NAAG is specifically targeted to astrocytes in the CNS. In the following sections, evidence regarding the unique intercellular neuron-glial metabolism of NAA and its derivative NAAG are assessed, and their possible roles in normal CNS and PNS development and as specifically targeted long-range glial cell-specific signals are considered.
METABOLISM OF NAA AND NAAG
NAA is the most enigmatic free amino acid in the vertebrate brain. Its concentration in the brain is one of the highest of all free amino acids where, as an osmolyte, it constitutes ϳ1% of the dry weight of the brain and 3-4% of total brain osmolarity. NAA is synthesized from acetyl-coenzyme A and Asp by NAA synthase (L-aspartate N-acetyltransferase; EC 2.3.1.17). Its singularity also includes the following: Within the CNS, NAA is synthesized primarily, although not exclusively, in neurons, where it is present in amounts up to 20 mM representing ϳ7% of neuron osmolarity and where it also exhibits a very high intracellular-extracellular gradient. NAA as an entity does not enter into neuronal protein metabolism or into any other neuronal metabolic pathways save one. In some neurons, a portion of NAA is converted into NAAG from NAA and Glu by an NAAG synthase (N-acetylaspartate-L-glutamate ligase), an as yet incompletely characterized enzyme (Tyson and Sutherland, 1998) .
Curiously, both NAA and NAAG are synthesized in cells that for the most part cannot utilize or hydrolyze them. As is the case for NAA, NAAG is an important osmolyte in brain where it is present at ϳ10% of the NAA concentration (Coyle, 1997) , a level that is also one of the highest concentrations for any dipeptide in the brain. Further, neuronal NAA and NAAG are both dynamic in nature and turn over within days by virtue of their continuous efflux in a regulated intercompartmental cycling between neurons and macroglial cells. NAA cycles between neurons and oligodendrocytes, among the only cells that do contain large amounts of aspartoacylase (N-acyl-L-aspartate amidohydrolase; EC 3.5.1.15), the major NAA catabolic enzyme in the brain (Baslow et al., 1999) . The NAAG derived from NAA appears to undergo a cycle similar to NAA, but with the catabolic enzyme in this case, NAAG peptidase (glutamate carboxypeptidase; EC 3.4.17.21), present on the surface of virtually all astrocytes, and absent in cultured oligodendrocytes and microglia (Berger et al., 1999) . At present, other than the genetic aspartoacylase inactivation that results from the CD mutations, there are no selective inhibitors known for the NAA metabolic enzymes or for NAAG synthase. However, selective inhibitors of NAAG peptidase have been reported (Slusher et al., 1999) .
IDENTIFICATION OF A UNIQUE TRICELLULAR METABOLIC NAAG CYCLE IN THE BRAIN
The recently identified cellular separation of the two anabolic and two catabolic enzymes in the NAAG cycle points to an unusual three-cell compartmentalization involving neurons (NAA and NAAG synthases), astrocytes (NAAG peptidase), and oligodendrocytes (aspartoacylase). Those neurons that may synthesize NAAG from NAA and Glu target the release of the NAAG to astrocytes, where it is cleaved at their cell surfaces into NAA and Glu. The Glu is taken up by astrocytes, where it may be recycled to neurons via the Glu-glutamine (Gln) cycle (Rothman et al., 1999) , with Gln synthesized in astrocytes by Gln synthase (glutamate-ammonia ligase; EC 6.3.1.2) and Glu produced in neurons by glutaminase (L-glutamine amidohydrolase; EC 3.5.1.2). For rapid hydrolysis and removal of the residual NAA extracellular product, nearby oligodendrocytes must act to complete this newly identified, complex, and metabolically unique tricompartmental cycle. Thus, the recent discovery of the second compartments for NAA and NAAG metabolism indicates that not only is their anabolic metabolism coupled, but that their catabolic metabolism is coupled as well. In addition, the presence of NAAG aciduria in CD also suggests that there are no other important pathways for the catabolism of NAAG. This tricellular cycle is shown in Fig. 1 .
POTENTIAL FOR GLIAL CELL-SPECIFIC SIGNALING
The NAA and NAAG systems NAA and NAAG are major neuronal osmolytes, and in this capacity they can also serve as a cellular reservoir for Asp and Glu. In addition, as they are polar and ionizable hydrophilic molecules that undergo a regulated efflux into extracellular fluid (ECF), both probably play a role in water movement out of neurons (Baslow, 1999b ). NAA appears not to exhibit any neurotransmitter activity (Urenjak et al., 1991) . However, NAAG does, and thus it may have additional roles as a neurotransmitter in the CNS, acting as a partial agonist of N-methyl-D-aspartate receptors, and in the selective activation of the metabotropic Glu receptor mGluR3 in astrocytes (Wroblewska et al., 1998; Schoepp et al., 1999) . Nevertheless, the unique compartmentalization of their anabolic and catabolic enzymes now suggests that these substances may have still other important functions in the CNS.
Whereas the NAA cycle operates primarily between neurons and oligodendrocytes, the NAA-linked NAAG cycle operates between neurons, astrocytes, and oligodendrocytes and may represent the only metabolic se-quence that requires three of the brain's major cell types for its completion. These metabolic sequences contain all of the elements required for a signaling device that coordinates the complex physical and metabolic interactions of these cells. These elements include the following: a constant source of neuronal cell-specific signals (NAA and NAAG) liberated into extracellular space to establish a diffusion gradient; appropriate chemicalstream and gradient-responsive receptors (cell-specific glial metabolic enzymes) for cell signal-source recognition on target glial cells; and the ability of these glial cells, at some stage in their development, to migrate or grow toward the signal and to establish appropriate associations.
These neuronal signals are cell-specific in the CNS: NAA for oligodendrocytes and NAAG for astrocytes. However, astrocytes can communicate with oligodendrocytes as well, by means of the NAA product of neuronreleased NAAG. In addition, as a result of the NAA hydrolysis product that is produced by astrocytes, other cells including oligodendrocytes, which can synthesize both NAA (Bhakoo and Pearce, 2000) and NAAG, and microglia, which can also synthesize NAAG (Passani et al., 1998) , can have a primary interaction with astrocytes (NAAG), as well as a secondary interaction with oligodendrocytes (NAA). Additional and reverse signaling by end products of NAA and NAAG hydrolysis, including acetate, Glu, and Asp, may complete a series of bidirectional communication sequences. The potential signaling relationships for NAA and NAAG between neurons and glial cells are summarized in Table 1 and illustrated in Fig. 1 .
Other systems
Of interest, a third intercompartmental cycling acetylated molecule, acetylcholine (ACh), synthesized by neurons and targeted to other neurons, has also been reported to be a signaling device-one that elicits cell-cell adhesive contacts between neural growth cones and ACh sensing neurons (Tatsumi and Katayama, 1999) . This duality in the nature of the role of ACh, first as an intercellular signal from a source cell to a target cell to form a synapse, and thereafter as a synaptic transmitter between these cells, was previously unrecognized. As with the NAA-NAAG systems, the catabolic enzyme for ACh, acetylcholinesterase, is located on the target cell at the postsynaptic membrane. The ACh cycling system also clearly illustrates the three phases of intercellular relationships in the nervous system. These are initial cell recognition and guidance, cell-to-cell docking, and finally long-term functional interactions. Similar signaling roles for other osmotically important intercompartmental cycling substances in the vertebrate brain can be envisioned. These include N-acetyl-L-histidine, ␤-alanyl-Lhistidine (carnosine), and ␥-aminobutyryl-L-histidine (homocarnosine).
The generation of cell-to-cell signals using acyl derivatives of amino acids is apparently a very primitive signaling device and is reported to be present in many bacteria (Schaefer et al., 1996; Pearson et al., 1999) . These derivatives, including N-(3-oxododecanoyl) homoserine lactone, N-butyryl homoserine lactone, and hexanoyl homoserine lactone, are intercellular targeted signals called autoinducers that, after efflux from source cells, can stimulate bacteria to form associations of cells as sessile communities in biofilms, with the cells embed- ded within an exopolymeric matrix (Allison et al., 1998) . The anabolic process producing the signal substance takes place within cells, and an intracellular hexanoyl homoserine lactone synthase has been identified in Vibrio fisheri (Schaefer et al., 1996) . The catabolic process is extracellular, and an exopolysaccharide lyase has been found to be secreted into culture media from dense biofilm cultures of Pseudomonas fluorescens, whose specific role appears to be the extracellular enzymatic degradation of exopolymers for detachment of cells under certain conditions (Allison et al., 1998) . In P. aeruginosa, there is also a specific signaling mutant that fails to form normal biofilms. However, these mutants can be made to form normal biofilms when grown in the presence of a synthetic signal molecule (Davies et al., 1998) . The human aspartoacylase enzyme also appears to be very primitive in origin, and regions suggested to form its catalytic core have been identified encoded in the genome of the bacterium Prochlorococcus marinus (Hess, 1997) .
Based on the compelling metabolic evidence, as well as examples from other systems, it is possible that NAA and its derivative, NAAG, function in both developing and mature brains as components of a much larger cellular chemical communication system; these substances target glial cells and may act as neuronal beacons, guiding astrocytes and oligodendrocytes to form their complex specific physical and metabolic associations with neurons and with each other. Furthermore, the continuous efflux of these substances from neurons may also serve as the metabolic glue to maintain these associations over long periods of time.
DEVELOPMENT OF THE CONCEPT OF GLIAL CELL-SIGNALING ROLES FOR NAA AND NAAG
NAA
Although there is no direct evidence for glial cellsignaling roles for NAA or NAAG in the vertebrate nervous system at present, the recent observations of the separation of the enzymes involved in the NAA and NAAG metabolic sequences between neurons and specific glial-cell types in the CNS provide strong circumstantial evidence for this conclusion. Until now, the concept of such a specific glial cell-signaling role for NAA in the CNS was not considered, although an NAA signaling role in the PNS between peripheral axons and Schwann cells has been proposed (Berger and Schwab, 1996) . In this case, NAA was considered a secondary signal produced by the hydrolysis of NAAG.
NAAG
In contrast, much speculation that NAAG had specific glial cell-signaling roles in the CNS and PNS has been offered. A possible role in the CNS was based on the observation that cultured rat brain oligodendrocytes and microglia both contain NAAG, and Passani et al. (1998) proposed that NAAG may be involved in cell communication along with a host of other neuropeptides and amino acid transmitters produced by these cells. Further, Berger et al. (1999) observed that NAAG peptidase was present in astrocytes and suggested that NAAG released from neurons may be a signal to astrocytes to express this enzyme. It was also suggested that NAAG might cue astrocytes to proliferate. Although the fate of the NAA product released by the action of NAAG peptidase in the CNS was not considered, these authors did speculate that the Glu liberated in extracellular space might act on glial Glu receptors, and might then be removed by glial or neuronal Glu transporters. Astrocytes are known to be Glu-responsive and to play important roles in the regulation of glutamatergic signaling and neuronal firing rates. Therefore, NAAG via the action of its peptidase was suggested as an important mediary of neuronal-glial communication. (2) Oligodendrocytes can send the NAAG message to astrocytes by synthesizing and liberating this substance.
(3) Astrocytes can send an NAA message to oligodendrocytes by hydrolysis of neuronal NAAG, active uptake of Glu, and release of the residual NAA product into ECF.
(4) Microglia may be able to synthesize NAA or take up neuronal or astrocyte liberated NAA to synthesize NAAG. Microglia may then be able to signal astrocytes and then oligodendrocytes by liberating NAAG into ECF.
(5) The end products of oligodendrocyte NAA hydrolysis, acetate and Asp, may serve as the return message to neurons or astrocytes.
(6) The converted Glu into Gln that is returned to neurons by astrocytes may serve as their return message to neurons.
(7) In each of these cases, the message may be contained in both the substance itself and its concentration; cells can use this information to interpret the source, direction, and the distance from the message source. Finally, Berger and Schwab (1996) working with cultured Schwann cells found NAAG peptidase on the extracellular side of the Schwann cell plasma membrane and suggested a role for this enzyme, via its catabolic NAAG products, in peripheral neuron-glial interactions, including axon ensheathment and myelination. It should be emphasized that potential myelinating oligodendrocytes in the CNS and potential myelinating Schwann cells in the PNS are completely different with regard to their NAA and NAAG metabolism. By virtue of their enzyme-restricted capabilities, oligodendrocytes could respond to an NAA signal, whereas Schwann cells are more like CNS astrocytes and could respond to an NAAG signal. This similarity in Schwann cell and astrocyte NAAG metabolism may be a cell recognition factor in the exclusion of Schwann cells from entering the CNS at peripheral nerve entry zones by astrocytes (Wilby et al., 1999) . Conversely, this difference in enzyme-restricted capabilities between CNS oligodendrocytes and PNS Schwann cells may also account for one of the reasons that CNS demyelinating diseases, such as CD, are not reflected in the PNS.
THE POSSIBLE RELATIONSHIP BETWEEN CD AND NEURON-GLIAL SIGNALING
As a result of the aspartoacylase deficiency in oligodendrocytes in CD, the NAA level in ECF becomes elevated up to 1,000-fold, from normal micromolar quantities to millimolar quantities. At these concentrations, NAA inhibits astrocyte hydrolysis of NAAG (Leshinsky et al., 1997) , and so NAAG levels would also be expected to rise. This appears to be the case in CD, where abnormally elevated concentrations of these substances diffuse out of the brain into the blood, and their removal via the kidneys results in the NAA and NAAG aciduria that is part of the CD syndrome.
Moreover, in CD, NAA and NAAG levels in the brain are elevated so that there is probably no longer a recognizable single-point source for target cell recognition. Therefore, if the roles of these glial target-specific substances are to establish communication and order between neurons and macroglial cells, it follows that in CD-where this communication system is compromised-the result would be a higher degree of disorder. It can further be anticipated that as the needs of the CNS increase with somatic and sensory development, continuing disorder in communication would result in the progressive failure of the CNS. This would be expected to lead to clinically observed progressive deterioration in neural function, as indeed is found in CD.
CONCLUSIONS
Several unique metabolic sequences for NAA metabolism in the vertebrate CNS are now recognized. They are the NAA system between neurons and oligodendrocytes, and the NAA-NAAG system, which requires the interaction of the three major cell types, neurons, astrocytes, and oligodendrocytes. These are important metabolic sequences as evidenced by the profound neurological consequences that result from the aspartoacylase deficiency in CD and inability to hydrolyze NAA. The metabolites in these sequences, both the primary signal substances and their hydrolysis products, are found in high concentrations in the brain, and several are neuroactive. Taken together, NAA, NAAG, and their hydrolysis products have all the properties required of bidirectional cell communication systems necessary for the development of the brain. It also follows that if these substances are necessary signals for the construction and maintenance of the normal nervous system, then any alteration in these signals may initiate a deconstruction of the nervous system, with consequent neuropathology (Pettmann and Henderson, 1998; Marks and Berg, 1999) , at any developmental stage.
These newly observed intercellular metabolic relationships between NAA, NAAG, and their target cells lead to the development of a new, unifying hypothesis, which may explain the hitherto incompletely understood functions of the NAA and NAAG systems, as well as the way in which the brain is organized. Briefly stated, this hypothesis suggests that although NAA and NAAG in the CNS may have a variety of important functions, a primary role is neuronal-glial cell-specific signaling and communication. NAA targeted to oligodendrocytes and NAAG targeted to astrocytes can signal their target cells to establish appropriate neural-glial associations. In this way, these substances may control several aspects of the development and interaction of brain cells and thus play a key role in the establishment and maintenance of a normal, functional vertebrate nervous system.
